Report from Sloan-Kettering Institute. Enzyme therapy and nutritional depletion of tumors.
D000421:Alcaligenes / Q000201:enzymology; D000642:Ammonia-Lyases / Q000627:therapeutic use; D000818:Animals; D001215:Asparaginase / Q000627:therapeutic use; D002268:Carboxypeptidases / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D002460:Cell Line; D057487:Enzyme Therapy; D005972:Glutaminase / Q000627:therapeutic use; D006801:Humans; D007942:Leukemia, Experimental / Q000188:drug therapy; D008113:Liver Neoplasms / Q000188:drug therapy; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000378:metabolism; D012513:Sarcoma, Experimental / Q000188:drug therapy
D002268:Carboxypeptidases; D001215:Asparaginase; D005972:Glutaminase; D000642:Ammonia-Lyases